3 Healthcare Stocks We Think Twice AboutPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
3 Reasons to Avoid RVTY and 1 Stock to Buy InsteadRevvity’s 14.9% return over the past six months has outpaced the S&P 500 by 5.6%, and its stock price has climbed to $112.79 per share. This performance may ...
3 S&P 500 Stocks We’re Skeptical OfThe S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
2 Profitable Stocks with Impressive Fundamentals and 1 We Turn DownEven if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs PeersAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...
The Top 5 Analyst Questions From Revvity’s Q1 Earnings CallRevvity’s first quarter results were well received by the market, as the company delivered stronger-than-expected organic growth and margins. Management attr...
3 Cash-Producing Stocks That Concern UsGenerating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
RVTY Q1 2026 Deep Dive: Portfolio Pruning and AI Investments Shape OutlookLife sciences company Revvity (
NYSE:RVTY) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 9.3% year on year to $686.9 million. T...
Why Is Revvity (RVTY) Stock Rocketing Higher TodayWhat Happened? Shares of life sciences company Revvity (
NYSE:RVTY) jumped 7.3% in the morning session after its first-quarter 2026 results surpassed Wall Str...
Revvity (NYSE:RVTY) Beats Q1 CY2026 Sales ExpectationsLife sciences company Revvity (
NYSE:RVTY) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 7% year on year to $711.1 million....
Revvity (NYSE:RVTY) Surprises With Q1 CY2026 SalesLife sciences company Revvity (
NYSE:RVTY) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 7% year on year to $711.1 milli...
Revvity Earnings: What To Look For From RVTYLife sciences company Revvity (
NYSE:RVTY) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. Revvity beat analysts’ r...
3 Reasons to Avoid RVTY and 1 Stock to Buy InsteadRevvity currently trades at $94.26 per share and has shown little upside over the past six months, posting a small loss of 1.5%. The stock also fell short of...
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...
3 S&P 500 Stocks with Warning SignsThe S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Research Tools & Consumables Stocks Q4 Results: Benchmarking Revvity (NYSE:RVTY)As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry,...
